APOGEE THERAPEUTICS INC (APGE) Stock Earnings & Estimates
USA - NASDAQ:APGE - US03770N1019 - Common Stock
38.42 USD
+0.29 (+0.76%)
38.42 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 668.40% | N/A 325.16% | N/A 104.65% | N/A 66.13% | ||||
| EBITDA YoY % growth | N/A | N/A | -216.681M | N/A -33.10% | N/A -15.07% | N/A -5.28% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -30.727M | -93.003M -202.68% | -216.87M -133.19% | N/A -38.48% | N/A -22.50% | N/A -16.66% | N/A -29.97% | N/A 17.89% | N/A 122.74% | N/A 577.62% | N/A 123.03% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -3.29 -18.55% | N/A -44.96% | N/A -23.43% | N/A -11.79% | N/A 14.37% | N/A 1.27% | N/A 69.72% | N/A 527.88% | N/A 131.02% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.23 -42.74% | -1.42 -19.55% | -1.34 -41.32% | -1.48 -30.94% | -1.27 -3.32% | -1.01 28.88% | -1.15 14.45% | -1.19 19.90% | -1.24 2.05% | -1.26 -25.00% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | ||||||
| EBITDA Q2Q % growth | -66.225M -13.06% | -105.557M -39.46% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -78.25M -33.34% | -90.566M -19.35% | -83.212M -31.88% | -98.354M -34.43% | -85.034M -8.67% | -64.294M 29.01% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.13 -89.28% | -1.10 | -0.03 | -2.92% |
| Q1 2025 Q2Q % growth | -0.95 -48.44% | -1.27 | 0.32 | 25.36% |
| Q4 2024 Q2Q % growth | -1.19 -271.87% | -1.10 | -0.09 | -8.41% |
| Q3 2024 Q2Q % growth | -0.86 -68.63% | -0.79 | -0.07 | -9.03% |
| Q2 2024 Q2Q % growth | -0.60 84.21% | -0.62 | 0.02 | 2.99% |
| Q1 2024 Q2Q % growth | -0.64 | -0.62 | -0.02 | -2.86% |
| Q4 2023 Q2Q % growth | -0.32 | -0.50 | 0.18 | 35.92% |
| Q3 2023 Q2Q % growth | -0.51 | -0.42 | -0.09 | -22.03% |
| Q2 2023 Q2Q % growth | -3.78 | -1.74 | -2.04 | -117.74% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -6.47% | 0% | -2.75% |
| Revenue | N/A | N/A | N/A | N/A |